secondari
immunodefici
syndrom
constitut
wide
array
nongastrointestin
disord
gastrointestin
complic
disord
often
follow
common
theme
patient
signific
risk
infect
gastrointestin
tract
addit
cellular
chang
gastrointestin
tract
largest
immun
organ
bodi
malabsorpt
peptic
disord
dysmotil
problem
face
children
worldwid
human
immunodefici
viru
infect
malnutrit
far
common
secondari
immunodefici
state
howev
usa
develop
countri
diseas
come
excel
control
advent
highli
activ
antiretrovir
therapi
haart
result
decreas
incid
gastrointestin
complic
nevertheless
review
gastrointestin
complic
diseas
children
import
preval
worldwid
serv
model
complic
secondari
immunodefici
state
first
case
acquir
immun
defici
syndrom
aid
describ
earli
later
determin
caus
agent
infect
recogn
spectrum
diseas
rang
asymptomat
infect
fullblown
aid
aid
epidem
claim
estim
million
live
estim
million
peopl
acquir
bring
million
estim
number
peopl
global
live
viru
success
prevent
strategi
elect
cesarian
section
deliveri
chemoprophylaxi
pregnant
women
transmiss
rate
plummet
less
women
deliv
infant
furthermor
advent
haart
natur
histori
children
develop
countri
alter
markedli
howev
success
prevent
prophylaxi
realiz
develop
countri
hiv
infect
continu
increas
thu
grave
implic
children
especi
develop
nation
women
infect
therapeut
option
pregnant
women
time
limit
rna
viru
belong
lentiviru
famili
particular
tropism
surfac
antigen
cell
bind
receptor
initi
viral
cycl
viru
may
subsequ
replic
within
host
cell
altern
provir
dna
within
host
cell
may
remain
latent
cellular
activ
occur
human
lymphocyt
monocytesmacrophag
primari
cell
infect
although
cell
line
may
infect
well
net
effect
suppress
immun
system
progress
declin
lymphocyt
leav
patient
suscept
opportunist
recurr
bacteri
infect
gastrointestin
tract
main
sourc
infect
parenter
transmiss
exclud
vertic
transmiss
found
gastrointestin
tract
fetu
swallow
infect
amniot
fluid
blood
cervic
secret
breast
milk
viru
inocul
gastrointestin
tract
infect
fetu
enter
gutassoci
lymphoid
tissu
galt
tonsil
upper
intestin
tract
rate
acquisit
gastrointestin
tract
like
relat
quantiti
viru
person
transmit
immunolog
function
matur
patient
infect
mucos
infect
opportunist
infect
may
increas
transmiss
mycobacteri
infect
upregul
cc
chemokin
recptor
express
monocyt
facilit
entri
factor
tumor
necrosi
induc
nuclear
factor
nf
pathogen
induc
potent
induc
cellular
rout
potenti
transmit
across
gastrointestin
tract
includ
cell
dendrit
cell
epitheli
cell
cell
special
epitheli
cell
overlay
peyer
patch
transport
larg
macromolecul
microorgan
apic
surfac
basolater
surfac
human
transport
cell
vivo
report
dendrit
cell
bind
specif
dendrit
cellspecif
adhens
molecul
vitro
studi
support
role
dendrit
cell
transmit
howev
role
dendrit
cell
vivo
transmiss
yet
determin
epitheli
cell
express
select
transfer
epitheli
cell
transport
vitro
apic
basolater
surfac
virus
transfer
vitro
epitheli
cell
line
transmit
lamina
propria
lymphocyt
express
chemokin
receptor
support
replic
earli
infect
greater
proport
infect
lymphocyt
lamina
propria
peripher
blood
lymphocyt
abl
dissemin
viru
distant
site
deplet
cell
lamina
propria
blood
mucos
peripher
cell
deplet
monocyt
macrophag
becom
import
reservoir
viru
intestin
macrophag
promot
inflamm
carri
receptor
howev
blood
monocyt
differ
profil
infect
found
infect
blood
thereaft
take
resid
gut
stimul
opportunist
agent
proinflammatori
cytokin
villou
atrophi
gastrointestin
tract
dysfunct
coincid
high
level
viral
load
gut
dysfunct
gastrointestin
tract
produc
signific
clinic
symptom
contribut
morbid
mortal
children
infect
symptom
includ
weight
loss
vomit
diarrhea
malabsorpt
tabl
review
distinct
chang
cellular
milieu
gastrointestin
tract
patient
previou
studi
shown
activ
mucos
cell
play
role
pathogenesi
enteropathi
human
small
intestin
affect
morpholog
villi
crypt
manner
similar
seen
patient
infect
recent
magnitud
viral
burden
gastrointestin
tract
associ
villou
blunt
abnorm
morpholog
number
studi
associ
distinct
enteropathi
first
describ
kotler
et
al
studi
homosexu
men
control
seven
patient
diarrhea
weight
loss
abnorm
low
dxylos
absorpt
steatorrhea
without
evid
intestin
infect
jejun
rectal
biopsi
obtain
patient
diarrhea
jejun
biopsi
show
partial
villou
atrophi
crypt
hyperplasia
increas
number
intraepitheli
lymphocyt
first
histolog
descript
specif
patholog
process
occur
lamina
propria
small
intestin
patient
ullrich
et
al
also
defin
small
intestin
structur
adult
patient
microscop
found
lowgrad
small
bowel
atrophi
matur
defect
enterocyt
patient
find
also
support
enteropathi
character
mucos
atrophi
hyporegener
howev
investig
challeng
concept
suggest
find
could
attribut
undiagnos
enter
infect
miller
et
al
publish
histolog
find
children
infect
major
patient
normal
villou
architectur
mani
children
villou
blunt
associ
intercurr
enter
infect
distinct
featur
hyperplasia
lamina
propria
increas
intraepitheli
lymphocyt
appar
order
link
alter
morpholog
abnorm
intestin
function
bjarnason
et
al
studi
intestin
inflamm
ileal
structur
function
patient
wide
spectrum
diseas
state
patient
minim
symptomat
normal
intestin
absorpt
permeabl
yet
increas
gastrointestin
dysfunct
progress
aid
malabsorpt
bile
acid
vitamin
b
correl
morphometr
analysi
ileal
biopsi
unremark
patient
thu
signific
mucos
dysfunct
minor
ileal
morpholog
chang
malabsorpt
bile
acid
may
play
patholog
role
patient
aid
diarrhea
absorpt
defect
aid
enteropathi
use
dxylos
kinet
model
proxim
absorpt
studi
minim
histolog
abnorm
proxim
distal
biopsi
site
patient
diarrhea
enter
infect
dxylos
absorpt
low
absorpt
defect
sever
greater
would
expect
histolog
abnorm
found
thu
find
support
studi
show
littl
associ
histolog
characterist
small
bowel
absorpt
function
patient
infect
studi
support
direct
role
gastrointestin
malabsorpt
growth
failur
weight
loss
ullrich
et
al
describ
gastrointestin
malabsorpt
patient
low
level
lactas
enzym
brush
border
crypt
death
decreas
villou
surfac
area
decreas
mitot
figur
per
crypt
compar
control
patient
addit
keat
et
al
describ
absorpt
capac
intestin
permeabl
patient
malabsorpt
preval
group
patient
aid
common
asymptomat
patient
malabsorpt
correl
significantli
degre
immun
suppress
bodi
mass
index
mild
decreas
jejun
villou
height
crypt
depth
ratio
yet
sever
subtot
villou
atrophi
found
celiac
diseas
lim
et
al
found
disaccharidas
activ
decreas
proportion
increas
diseas
sever
although
associ
disaccharidas
level
weight
loss
addit
mosavi
et
al
found
correl
diarrhea
weight
loss
patient
recent
taylor
et
al
found
mild
histolog
chang
accompani
sever
disaccharidas
abnorm
howev
symptom
sever
enough
withdraw
lactos
patient
collect
studi
suggest
gastrointestin
malabsorpt
may
present
alway
associ
weight
loss
diarrhea
formal
studi
intestin
absorpt
children
limit
malabsorpt
occur
frequent
children
may
progress
diseas
one
studi
children
nonphysiolog
lactos
malabsorpt
gener
carbohydr
malabsorpt
associ
gastrointestin
symptom
nutrit
statu
find
confirm
other
anoth
studi
children
reveal
associ
diarrhea
nutrit
abnorm
dxylos
absorpt
also
associ
enter
infect
children
fat
protein
loss
malabsorpt
also
describ
sentongo
et
al
evalu
fat
malabsorpt
pancreat
exocrin
insuffici
use
fecal
enzym
assay
children
hormonestimul
pancreat
function
test
stool
dietari
fat
sampl
collect
perform
children
abnorm
fecal
elastas
level
preval
steatorrhea
pancreat
insuffici
confid
interv
associ
steatorrhea
pancreat
insuffici
growth
rna
viral
load
statu
type
antiretrovir
therapi
other
studi
support
absenc
associ
thu
clinic
signific
steatorrhea
pediatr
similar
absorpt
nutrient
unclear
etiolog
malabsorpt
infect
probabl
multifactori
cellular
milieu
lamina
propria
alter
significantli
infect
deplet
lymphocyt
intestin
tract
may
caus
chang
cytokin
environ
alter
intestin
function
viral
load
intestin
tract
may
consider
higher
measur
peripher
also
affect
mucos
gastrointestin
structur
function
studi
suggest
hypothes
includ
kotler
et
al
look
intestin
mucos
inflamm
individu
author
found
abnorm
histopatholog
patient
find
associ
alter
bowel
habit
high
tissu
antigen
level
observ
correl
advanc
diseas
tissu
detect
associ
abnorm
bowel
habit
mucos
histolog
tissu
content
cytokin
includ
tnf
higher
individu
control
increas
independ
intestin
infect
thu
reactiv
intestin
mucosa
could
associ
inflammatori
bowellik
syndrom
absenc
enter
pathogen
small
bowel
bacteri
overgrowth
anoth
sourc
gastrointestin
dysfunct
lead
malabsorpt
bacteri
overgrowth
may
due
aid
gastropathi
stomach
produc
small
amount
hydrogen
chlorid
allow
bacteri
pathogen
escap
acid
barrier
stomach
colon
duodenum
addit
iatrogen
hypochlorhidria
may
due
use
acidblock
agent
treatment
ongo
peptic
diseas
interestingli
author
found
relationship
gastric
ph
small
bowel
bacteri
colon
diarrhea
patient
enter
pathogen
associ
enter
dysfunct
discuss
advent
haart
gastrointestin
symptom
especi
associ
opportunist
infect
less
common
viral
burden
decreas
immunosuppress
less
effect
gastrointestin
function
ritonavir
proteas
inhibitor
combin
therapi
result
restor
gastrointestin
function
children
carbohydr
malabsorpt
steatorrhea
protein
loss
iron
defici
howev
one
studi
adult
found
similar
rate
fat
malabsorpt
patient
take
haart
take
haart
gastrointestin
tract
major
target
opportunist
infect
immunocompromis
children
spectrum
infect
depend
diseas
progress
develop
countri
improv
viral
suppress
associ
haart
opportunist
infect
gut
elsewher
less
common
howev
immunocompromis
children
continu
risk
infect
cytomegaloviru
cmv
herp
simplex
viru
hsv
cryptosporidium
microsporidia
previou
dogma
much
diarrhea
found
children
infect
associ
enter
pathogen
challeng
unusu
viral
parasit
infect
diagnos
result
better
diagnost
techniqu
howev
caus
diarrhea
signific
number
patient
remain
undiagnos
detect
viral
gastrointestin
infect
children
sometim
difficult
owe
limit
diagnost
techniqu
common
gastrointestin
viral
pathogen
children
cmv
pathogen
hsv
adenoviru
epsteinbarr
viru
varieti
unusu
virus
also
contribut
intestin
dysfunct
diarrhea
hsv
infect
immunocompromis
child
usual
repres
reactiv
latent
viru
acquir
earlier
life
gastrointestin
infect
hsv
commonli
involv
esophagu
caus
multipl
small
discret
ulcer
hsv
also
involv
area
intestin
tract
includ
colon
small
bowel
diagnosi
hsv
reli
recogn
multinucl
intranuclear
inclus
bodi
cowdri
type
groundglass
appear
mold
nuclei
squamou
epithelium
usual
infect
although
may
also
involv
intestin
glandular
epithelium
mesenchym
cell
hsv
monoclon
antibodi
stain
confirmatori
diagnosi
extens
involv
may
transmur
necrosi
develop
tracheoesophag
fistula
treatment
hsv
common
gastrointestin
pathogen
primari
site
involv
outlin
tabl
herpesvirus
also
detect
gut
individu
case
report
one
man
intestin
pseudoobstruct
dissemin
cutan
herp
zoster
reveal
posit
immunohistochemistri
herp
zoster
resect
portion
termin
ileum
area
focal
ulcer
viru
local
musculari
propria
myenter
plexi
throughout
entir
length
specimen
author
postul
locat
viru
gut
may
etiolog
factor
pseudoobstruct
cytomegaloviru
cmv
immunocompromis
child
like
hsv
repres
reactiv
latent
viru
acquir
earlier
life
cmv
one
common
viral
pathogen
children
report
incid
gastrointestin
involv
prehaart
era
vari
patient
studi
incid
rate
may
vari
base
techniqu
diagnosi
cmv
infect
rare
patient
tlymphocyt
count
greater
cellsmm
thu
haart
era
morbid
mortal
rate
cmvassoci
gastrointestin
diseas
diminish
cmv
may
involv
part
gastrointestin
tract
increas
incid
esophagu
colon
cmv
infect
usual
result
one
two
discret
singl
larg
ulcer
esophagu
colon
lesion
may
lead
sever
gastrointestin
bleed
hemodynam
instabl
cmv
inclus
bodi
discov
incident
asymptomat
patient
necessarili
reflect
diseas
patient
upper
intestin
cmv
diseas
dysphagia
upper
abdomin
symptom
wherea
diarrhea
common
coliti
diarrhea
wateri
bloodi
natur
children
may
system
ill
coliti
cmv
infect
patchi
natur
associ
sever
necrot
coliti
hemorrhag
cmv
usual
affect
cecum
right
colon
diagnosi
confirm
endoscopi
biopsi
histolog
appear
cmvinfect
cell
quit
uniqu
fig
cell
enlarg
contain
intranuclear
cytoplasm
inclus
bodi
nuclear
inclus
bodi
acidophil
often
surround
halo
cytoplasm
inclus
bodi
multipl
granular
often
basophil
cell
die
may
appear
smaller
smudg
poorli
defin
inclus
bodi
stain
cmv
antigen
show
mani
infect
cell
endotheli
cell
other
perivascular
mesenchym
cell
cmv
caus
vascul
target
cell
popul
thu
spread
cmv
occur
circul
infect
endotheli
cell
treatment
option
outlin
tabl
haart
establish
decreas
viral
burden
cmv
improv
count
cmv
treatment
may
discontinu
without
concern
reactiv
infect
unusu
viral
pathogen
describ
includ
human
papilloma
viru
epsteinbarr
viru
identifi
esophag
ulcer
patient
adenoviru
stomach
colon
also
report
often
difficult
identifi
prehaart
era
patient
excret
adenoviru
gastrointestin
tract
shorter
surviv
unusu
enter
virus
associ
diarrhea
children
virus
among
other
includ
astroviru
picobirnaviru
cegielski
et
al
studi
children
infect
tanzania
look
enter
virus
identifi
electron
microscopi
fecal
specimen
small
round
structur
virus
srsv
found
frequent
children
uninfect
children
chronic
diarrhea
rotaviru
coronaviruslik
particl
associ
infect
author
consid
srsv
may
associ
infect
could
lead
chronic
diarrhea
tanzanian
children
bacteri
infect
involv
gastrointestin
tract
children
infect
may
divid
three
group
bacteri
overgrowth
normal
gut
flora
pathogen
affect
immunocompromis
children
well
immunocompet
children
salmonella
shigella
campylobact
clostridium
difficil
aeromona
bacteri
infect
uniqu
immunocompromis
children
mycobacterium
avium
intracellular
complex
mac
studi
evalu
bacteri
overgrowth
children
although
gastric
hypoacid
associ
opportunist
enter
infect
bacteri
overgrowth
adult
patient
studi
found
associ
small
bowel
bacteri
overgrowth
common
find
group
patient
regardless
presenc
diarrhea
associ
hypochlorhydria
lactos
hydrogen
breath
test
shown
high
baselin
read
children
may
indirectli
suggest
bacteri
overgrowth
small
intestin
tract
detect
bacteri
overgrowth
small
bowel
usual
perform
quantit
duoden
aspir
bacteri
cultur
therapi
direct
treat
organ
often
anaerob
organ
occur
frequent
immunocompromis
patient
declin
incid
infect
bacteri
pathogen
develop
countri
link
improv
immun
associ
haart
howev
combin
morbid
mortal
rate
associ
bacteri
pathogen
develop
countri
approach
studi
patient
campylobact
infect
higher
rate
bacteremia
gener
popul
death
sepsi
due
organ
report
sever
immunodefici
patient
aid
despit
haart
coliti
c
difficil
also
common
immunosuppress
popul
owe
chronic
antibiot
use
impair
immun
system
pulvirenti
et
al
studi
patient
c
difficil
found
longer
hospit
stay
admiss
patient
without
c
difficil
infect
well
opportunist
infect
herp
viru
found
c
difficileassoci
diarrhea
studi
patient
diarrhea
howev
infect
c
difficil
appear
littl
impact
morbid
mortal
new
york
state
screen
studi
hospit
patient
haart
era
admit
diarrheal
diagnosi
c
difficil
infect
thu
even
haart
diarrhea
preval
often
associ
identifi
pathogen
seriou
complic
associ
activ
bacteri
enter
infect
immunodefici
children
treatment
option
outlin
tabl
intestin
infect
mycobacteria
includ
mycobacterium
tuberculosi
mac
atyp
mycobacteria
frequent
encount
bacteri
infect
patient
prehaart
era
becam
preval
prehaart
era
patient
live
longer
count
cellsmm
haart
era
dissemin
mac
colon
patient
success
prevent
howev
effect
haart
restor
count
prevent
mac
colon
infect
mac
usual
occur
late
stage
aid
children
count
lower
cellsmm
common
clinic
manifest
gastrointestin
infect
mac
includ
fever
weight
loss
malabsorpt
diarrhea
intestin
obstruct
result
lymph
node
involv
intussuscept
termin
ileiti
resembl
crohn
diseas
refractori
gastric
ulcer
often
found
sever
gastrointestin
hemorrhag
also
describ
endoscop
fine
white
nodul
may
seen
duodenum
duoden
mucosa
may
look
velveti
grayish
appear
segment
gastrointestin
tract
becom
infect
mac
histolog
diffus
histiocyt
infiltr
lamina
propria
blunt
small
intestin
villi
histiocyt
infiltr
recogn
hematoxylin
eosin
stain
acidfast
stain
pathognomon
infect
fig
advent
haart
immun
reconstitut
diseas
describ
like
immun
reaction
previous
quiescent
organ
becom
activ
improv
immun
function
associ
haart
occur
mani
patient
respond
haart
lymphaden
common
condit
although
abscess
appear
anywher
sever
abdomin
complaint
may
result
appropri
therapi
outlin
tabl
yet
organ
often
frustrat
treat
azithromycin
mg
given
combin
ethambutol
effect
agent
treatment
dissemin
avium
diseas
patient
infect
caution
must
exercis
administ
multidrug
regimen
mac
patient
receiv
concurr
haart
rifamycin
induc
cytochrom
enzym
acceler
metabol
clarithromycin
proteas
inhibitor
convers
clarithromycin
inhibit
enzym
result
increas
rifabutin
toxic
net
result
treatment
regimen
extrem
difficult
toler
manag
especi
sicker
patient
clarithromycin
azithromycin
must
administ
combin
agent
ethambutol
prevent
emerg
macrolid
resist
entiti
bacteri
enter
describ
adult
studi
orenstein
kotler
evalu
ileal
colon
biopsi
patient
aid
diarrhea
found
bacteria
similar
adher
e
coli
along
intestin
epitheli
border
similar
find
document
kotler
et
al
show
adher
bacteria
adult
patient
aid
infect
local
primarili
cecum
right
colon
three
distinct
histopatholog
pattern
adher
observ
attach
effac
lesion
bacteria
intercal
microvilli
aggreg
bacteria
loos
attach
damag
epithelium
bacteri
cultur
frozen
rectal
biopsi
yield
e
coli
patient
find
suggest
chronic
infect
adher
bacteria
also
produc
syndrom
aidsassoci
diarrhea
look
back
evalu
orenstein
dieterich
found
enteropathogen
bacteri
infect
overlook
initi
examin
conclud
accur
diagnos
specimen
evalu
laboratori
expertis
hiv
h
pylori
preval
significantli
differ
patient
patient
investig
found
seropreval
h
pylori
lower
patient
especi
count
declin
advanc
diseas
protect
h
pylori
may
result
frequent
antibiot
use
correl
advanc
dysfunct
immun
state
result
decreas
inflammatori
respons
organ
remiss
highgrad
gastric
mucosaassoci
lymphoid
tissu
malt
lymphoma
follow
h
pylori
erad
haart
patient
aid
treatment
h
pylori
children
similar
noninfect
children
special
attent
drug
interact
earli
cryptosporidiosi
regard
aidsdefin
diseas
opportunist
intestin
pathogen
becam
import
caus
chronic
diarrhea
lead
high
morbid
mortal
rate
immunocompromis
patient
date
effect
chemotherapi
avail
introduct
proteas
inhibitor
haart
regimen
incid
cryptosporidiosi
patient
aid
declin
substanti
develop
countri
howev
develop
nation
gastrointestin
infect
c
parvum
preval
carri
high
morbid
mortal
rate
although
cryptosporidium
initi
describ
anim
first
note
caus
enterocol
immunocompromis
immunocompet
human
intact
tcell
respons
primari
mechan
confer
protect
organ
thu
patient
abnorm
tcell
function
number
risk
spectrum
sever
diseas
immunocompromis
individu
cryptosporidiosi
correl
sever
diseas
found
individu
defect
tcell
respons
overal
frequenc
infect
seem
relat
sever
immunodefici
specif
disord
cryptosporidium
usual
affect
gastrointestin
tract
although
found
organ
includ
biliari
tract
pancrea
respiratori
tract
immunocompet
individu
diarrhea
selflimit
wherea
immunocompromis
patient
may
protract
associ
signific
malabsorpt
nutrit
compromis
small
intestin
primari
target
although
occur
part
intestin
tract
esophag
cryptosporidiosi
also
describ
one
child
adult
clayton
et
al
describ
two
pattern
enter
cryptosporidiosi
one
accompani
sever
clinic
diseas
signific
malabsorpt
major
organ
found
proxim
small
bowel
wherea
less
sever
clinic
diseas
seen
patient
colon
diseas
infect
note
stool
patient
proxim
small
bowel
infect
cryptosporidium
show
crypt
hyperplasia
villou
atrophi
lamina
propria
inflammatori
infiltr
abnorm
dxylos
absorpt
greater
weight
loss
shorter
surviv
greater
need
intraven
hydrat
hyperaliment
patient
colon
diseas
studi
absorpt
nutrient
show
invers
correl
activ
infect
shown
alter
vitamin
b
dxylos
absorpt
lactulos
mannitol
urinari
excret
ratio
intestin
function
improv
patient
whose
oocyt
count
reduc
treatment
paromomycin
symptomat
cryptosporidiosi
document
mani
immunocompet
children
immunodefici
children
wherea
asymptomat
popul
cryptosporidium
found
immunocompet
immunodefici
children
spiramycin
mg
per
kg
daili
day
caus
signific
reduct
shed
infecti
oocyst
gastrointestin
symptom
develop
children
treat
asymptomat
infect
wherea
children
treat
develop
gastrointestin
symptom
diagnosi
cryptosporidiosi
made
identifi
organ
duoden
aspir
stool
tissu
sampl
biopsi
hematoxylinand
eosinstain
section
organ
found
row
cluster
basophil
spheric
structur
diamet
attach
microvil
border
epitheli
cell
fig
tip
later
aspect
villi
show
greatest
number
organ
small
intestin
colon
epithelium
crypt
surfac
epitheli
involv
appear
equal
cryptosporidium
also
stain
posit
giemsa
neg
mucou
stain
acidfast
stain
stool
sampl
one
wide
use
method
determin
whether
patient
cryptosporidiosi
recent
sensit
specif
method
diagnos
cryptosporidiosi
includ
fluoresceinlabel
igg
monoclon
antibodi
treatment
cryptosporidiosi
children
infect
often
difficult
diseas
chronic
protract
diffus
wateri
diarrhea
dehydr
sever
differ
agent
use
erad
organ
vari
success
rate
effect
treatment
improv
immunolog
function
nutrit
statu
advent
haart
mani
children
immun
function
restor
lower
incid
preval
cryptosporidium
infect
introduct
haart
patient
sever
debilit
cryptosporidium
infect
result
increas
count
peripher
blood
clearanc
organ
also
produc
mark
increas
count
rectal
mucosa
biopsi
suggest
may
main
mechan
clear
parasit
octreotid
therapi
acut
chronic
diarrhea
coincid
improv
nutrit
statu
erad
cryptosporidium
one
patient
investig
use
bovin
hyperimmun
colostrum
benefit
macrolid
azithromycin
shown
promis
treatment
cryptosporidium
infect
effect
proteas
inhibitor
therapi
cryptosporidium
test
cell
cultur
system
nelfinavir
moder
inhibit
host
cell
invas
period
h
indinavir
nelfinavir
ritonavir
inhibit
parasit
develop
significantli
inhibitori
effect
increas
aminoglycosid
paromomycin
combin
proteas
inhibitor
indinavir
ritonavir
lesser
extent
saquinavir
compar
proteas
inhibitor
alon
thu
proteas
inhibitor
therapi
may
directli
rather
indirectli
effect
immun
system
inhibit
growth
cryptosporidium
amadi
et
al
found
cours
nitazoxanid
improv
diarrhea
help
erad
parasit
improv
mortal
children
zambia
microsporidia
oblig
intracellular
protozo
parasit
infect
varieti
cell
type
mani
differ
speci
anim
organ
first
describ
recogn
caus
diseas
nonhuman
host
first
descript
microsporidia
enterocytozoon
bieneusi
human
pathogen
microsporidia
sinc
describ
common
human
pathogen
infect
microsporidia
typic
occur
patient
sever
depress
tlymphocyt
count
one
largest
case
studi
intestin
microsporidiosi
patient
infect
describ
orenstein
et
al
adult
patient
aid
aidsrel
complex
chronic
nonpathogen
diarrhea
e
bieneusi
diagnos
electromicroscopi
patient
jejun
biopsi
posit
duoden
biopsi
parasit
spore
clearli
visibl
light
microscopi
biopsi
infect
confin
enterocyt
locat
tip
intestin
villu
histolog
find
includ
villou
atrophi
cell
degener
necrosi
slough
investig
found
microsporidia
mani
patient
chronic
unexplain
diarrhea
evalu
prehaart
era
e
bieneusi
document
children
without
diarrhea
develop
countri
make
fairli
ubiquit
region
world
speci
microsporidia
includ
encephalitozoon
septata
intestinali
caus
signific
enter
diseas
diarrhea
wast
malabsorpt
septata
intestinali
differ
e
bieneusi
tendenc
dissemin
infect
enterocyt
well
macrophag
fibroblast
endotheli
cell
microsporidia
found
increas
frequenc
patient
infect
document
almost
everi
tissu
organ
bodi
epitheli
mesenchym
neural
cell
microsporidia
caus
inflamm
cell
death
varieti
symptom
includ
short
breath
sinus
diarrhea
wast
left
untreat
microsporidiosi
signific
caus
mortal
treatment
microsporidia
includ
albendazol
reliev
clinic
symptom
elimin
microsporidi
spore
fece
especi
less
common
pathogen
e
intestinali
e
bieneusi
challeng
treat
although
therapi
fumagillin
analog
antiangiogenesi
agent
shown
promis
result
studi
show
atovaquon
effect
treatment
well
indirect
treatment
improv
immun
system
haart
also
effect
clear
organ
isospora
belli
recogn
opportunist
small
bowel
pathogen
patient
infect
organ
common
tropic
subtrop
climat
isosporiasi
diagnos
identif
oocyt
stool
biopsi
diagnosi
critic
unlik
cryptosporidiosi
microsporidiosi
therapi
effect
belli
found
within
enterocyt
within
cytoplasm
organ
stain
poorli
although
central
nucleu
larg
nucleolu
perinuclear
halo
give
characterist
appear
infect
produc
mucos
atrophi
tissu
eosinophilia
cours
trimethoprimsulfamethoxazol
effect
therapi
recurr
diseas
prevent
ongo
prophylaxi
combin
drug
ciprofloxacin
although
effect
accept
altern
sulfa
allergi
therapi
isospora
includ
pyrimethamin
also
indic
patient
sulfa
allergi
blastocysti
homini
usual
consid
nonpatholog
parasit
describ
patient
chronic
diarrhea
infect
organ
pathogen
immunocompromis
patient
caus
mild
prolong
recurr
diarrhea
effect
therapi
includ
diiodohydroxyquinolin
mg
oral
three
time
daili
day
protozoan
infect
found
patient
entameba
histolytica
entameba
coli
entameba
hartmanni
endolimax
nana
giardia
lamblia
case
candidiasi
gastrointestin
tract
common
fungal
infect
children
esophagu
primari
target
candida
infect
occur
major
patient
cours
ill
prehaart
era
also
second
frequent
aidsdefin
diseas
second
preval
pneumocysti
carinii
current
success
viral
suppress
invas
candida
rare
children
haart
patient
candida
esophag
complain
odynophagia
dysphagia
may
often
vomit
recurr
abdomin
pain
children
often
oral
thrush
coincid
dissemin
invas
candida
esophag
although
absenc
oral
thrush
preclud
diagnosi
candida
esophag
one
studi
oral
candidiasi
preced
diagnosi
candida
esophag
children
risk
factor
includ
low
count
prior
antibiot
use
histopatholog
yeast
form
within
intact
mucosa
confirm
invas
diseas
contrast
colon
yeast
found
overli
intact
mucos
surfac
necrot
tissu
organ
best
seen
grocott
methenamin
silver
method
period
acidschiff
stain
upper
gastrointestin
studi
suggest
candida
esophag
diffus
mucos
irregular
fig
upper
gastrointestin
endoscopi
biopsi
appropri
stain
sensit
test
determin
invas
candidiasi
esophagu
candidiasi
also
occur
stomach
well
small
bowel
acid
barrier
suppress
either
intrins
decreas
gastric
acid
product
iatrogen
use
potent
acid
blocker
numer
effect
therapi
describ
treat
candida
upper
gastrointestin
tract
includ
fluconazol
ketoconazol
itraconazol
ketoconazol
hepat
sideeffect
fluconazol
itraconazol
usual
well
toler
effect
sever
invas
diseas
either
topic
intraven
amphotericin
use
agent
oral
miconazol
nystatin
indic
invas
candida
dissemin
histoplasmosi
develop
adult
patient
aid
midwestern
region
unit
state
elsewher
clinic
sign
symptom
relat
infect
may
indol
left
untreat
carri
signific
morbid
mortal
likelihood
diseas
higher
patient
count
cellsmm
enterocol
associ
infect
colonoscopi
plaqu
ulcer
pseudopolyp
skip
area
frequent
seen
cryptococc
gastrointestin
diseas
identifi
patient
dissemin
cryptococcu
infect
esophagu
colon
involv
frequent
p
carinii
infect
gastrointestin
tract
also
describ
gastrointestin
pneumocystosi
develop
hematogen
lymphat
dissemin
lung
reactiv
latent
gastrointestin
infect
administr
aerosol
pentamidin
increas
risk
develop
extrapulmonari
spread
pcp
pcp
infect
occur
throughout
gastrointestin
tract
lamina
propria
foami
exud
p
carinii
organ
found
within
although
rare
infect
colon
also
caus
diarrhea
children
etiolog
diarrhea
unclear
autonom
dysfunct
anoth
potenti
mechan
noninfecti
diarrhea
previous
describ
clinic
children
autonom
neuropathi
sweat
urinari
retent
abnorm
cardiovascular
hemodynam
possibl
autonom
denerv
may
contribut
diarrhea
patient
infect
suggest
griffin
et
al
neuronspecif
polyclon
antibodi
appli
jejun
biopsi
signific
reduct
axon
densiti
villi
pericrypt
lamina
propria
patient
infect
compar
control
greatest
reduct
patient
diarrhea
octreotid
therapi
shown
promis
result
patient
lastli
drug
sideeffect
consid
mani
antiretrovir
therapi
caus
chronic
diarrhea
gastrointestin
toxic
tabl
motil
problem
esophagu
stomach
report
sourc
upper
gastrointestin
complaint
includ
vomit
dysphagia
nausea
dyspepsia
motil
abnorm
may
primari
secondari
infecti
inflammatori
diseas
respect
organ
hypertens
lower
esophag
sphincter
incomplet
relax
esophag
hypocontract
nonspecif
motil
disord
describ
patient
normal
intact
esophag
mucosa
gastric
empti
especi
patient
infect
advanc
diseas
may
delay
document
gastric
scintigraphi
howev
delay
gastric
empti
alway
correl
upper
gastrointestin
symptom
small
bowel
motil
studi
adult
infect
minim
advanc
diseas
gastric
empti
solid
delay
empti
liquid
acceler
compar
control
abnorm
esophag
motil
pattern
found
patient
normal
endoscopi
prior
motil
studi
thu
absenc
infecti
inflammatori
diseas
patient
appropri
symptom
motil
studi
empir
trial
prokinet
agent
consid
care
consider
drug
interact
esophag
ulcer
result
intercurr
opportunist
infect
idiopath
oral
esophag
ulcer
describ
children
adult
ulcer
characterist
larg
may
singl
multipl
natur
fig
ulcer
locat
mid
distal
esophagu
controversi
exist
regard
pathogenesi
ulcer
investig
identifi
ulcer
base
wherea
other
treatment
option
ulcer
limit
includ
steroid
therapi
encourag
result
thalidomid
howev
chronic
lowdos
thalidomid
prevent
recurr
oral
esophag
aphthou
ulcer
addit
potenti
teratogen
effect
signific
portion
children
receiv
thalidomid
develop
rash
preclud
use
drug
signific
caution
exercis
use
thalidomid
overal
haart
posit
impact
esophag
diseas
occurr
relaps
diagnost
approach
child
gastrointestin
symptom
outlin
tabl
comprehens
clinic
histori
taken
focu
estim
calor
intak
evalu
abdomin
symptom
diarrhea
vomit
abdomin
pain
growth
histori
also
review
physic
examin
focu
assess
nutrit
state
possibl
intestin
hepatobiliari
diseas
diarrheal
symptom
everi
child
complet
evalu
bowel
pathogen
preced
diagnost
studi
treatment
pathogen
may
result
resolut
symptom
investig
enter
infect
includ
studi
organ
outlin
preced
section
infecti
diarrhea
child
antiretrovir
regimen
initi
new
medic
note
mani
medic
produc
signific
gastrointestin
sideeffect
see
tabl
everi
effort
made
correl
time
initi
drug
onset
symptom
clinician
keep
mind
children
activ
enter
infect
may
also
secondari
problem
malabsorpt
clinic
histori
physic
examin
suspici
malabsorpt
without
enter
infect
next
step
includ
evalu
specif
nutrient
absorpt
carbohydr
malabsorpt
detect
lactos
breath
hydrogen
test
measur
hydrogen
product
respons
oral
lactos
load
rais
baselin
breath
hydrogen
earli
peak
hydrogen
product
suggest
bacteri
overgrowth
appropri
treatment
initi
lactos
malabsorpt
result
level
hydrogen
product
part
per
million
baselin
min
ingest
dietari
chang
made
dxylos
absorpt
test
also
help
determin
absorpt
capac
gastrointestin
tract
dxylos
absorb
sugar
requir
activ
transport
uptak
enterocyt
thu
dxylos
serum
level
administr
test
dose
reflect
absorpt
abil
gastrointestin
tract
integr
mucos
surfac
younger
children
administ
dose
g
per
kg
bodyweight
given
oral
overnight
fast
older
children
adolesc
maximum
dose
g
serum
level
obtain
h
ingest
urin
sampl
may
obtain
h
ingest
well
fat
malabsorpt
determin
fecal
fat
collect
highfat
diet
administ
sever
day
collect
initi
throughout
collect
period
altern
method
keep
dietari
fat
intak
record
period
fecal
fat
collectionth
stool
analyz
total
fat
content
fecal
fat
compar
amount
ingest
coeffici
fat
absorpt
calcul
ten
percent
ingest
fat
stool
consid
abnorm
altern
sudan
stain
may
perform
random
stool
sampl
may
help
quick
test
fat
malabsorpt
although
reliabl
quantif
fecal
elastas
may
help
determin
whether
fat
malabsorpt
pancreat
origin
lastli
rais
fecal
alpha
antitrypsin
level
suggest
protein
loss
gut
noninvas
studi
describ
help
document
determin
etiolog
malabsorpt
diarrhea
vomit
endoscopi
either
upper
lower
biopsi
appropri
cultur
fluid
may
use
miller
et
al
confirm
histolog
abnorm
children
undergo
upper
endoscopi
patient
seri
clinic
manag
child
chang
endoscop
evalu
high
diagnost
yield
support
investig
specif
gastrointestin
symptom
predict
abnorm
find
endoscopi
advanc
diseas
stage
increas
number
symptom
seem
predict
histolog
studi
small
bowel
may
aid
determin
degre
villou
blunt
electron
microscopi
special
stain
opportunist
pathogen
perform
quantit
bacteri
cultur
parasit
evalu
duoden
fluid
obtain
endoscopi
perform
characterist
detect
organ
per
ml
duoden
fluid
confirm
bacteri
overgrowth
import
obtain
anaerob
quantit
cultur
howev
studi
shown
endoscopi
improv
diagnost
yield
compar
stool
examin
patient
intestin
infect
except
diagnosi
cmv
addit
studi
found
flexibl
sigmoidoscopi
use
full
colonoscopi
diagnos
infect
special
histolog
stain
fungal
mycobacteri
viral
infect
increas
diagnost
yield
routin
hematoxylin
eosin
stain
treatment
intestin
infect
outlin
tabl
previou
section
therapi
gastrointestin
malabsorpt
direct
toward
underli
diagnosi
clinic
symptomat
lactos
malabsorpt
found
lactosefre
diet
initi
complianc
may
difficult
mani
food
contain
lactos
children
limit
effect
dietari
lactos
take
exogen
lactas
use
lactasetr
milk
care
consider
calcium
vitamin
intak
children
infect
suscept
low
bone
miner
densiti
malabsorpt
protein
fat
protein
hydrolys
diet
gastrointestin
complic
secondari
immunodefici
syndrom
tri
mani
supplement
poorli
toler
unpalat
circumst
special
supplement
may
need
administ
supplement
feed
tube
peptic
motil
disord
treat
children
pay
care
attent
potenti
drug
interact
antiretrovir
regimen
varieti
disord
tabl
caus
secondari
immunodefici
effect
gastrointestin
tract
overal
disord
preval
either
primari
immunodefici
prematur
infant
children
cancer
associ
exposur
immunosuppress
cytotox
medic
includ
children
graft
vs
host
diseas
children
proteinlos
enteropathi
associ
loss
immunoglobulin
gastrointestin
tract
immunodefici
underli
disord
gener
children
immunodefici
risk
mani
complic
experienc
children
infect
gastrointestin
tract
infect
among
common
problem
face
children
secondari
immunodefici
malnutrit
common
caus
immunodefici
worldwid
nutrit
statu
immun
long
link
mani
diseas
state
describ
p
carinii
pneumonia
kaposi
sarcoma
known
opportunist
diseas
first
describ
otherwis
healthi
malnourish
children
adult
develop
nation
associ
led
investig
conclud
nutrit
alon
affect
immunolog
respons
individu
malnourish
children
profound
involut
lymphoid
tissu
includ
thymic
atrophi
diminish
paracort
region
lymph
node
young
infant
children
proteincalori
malnutrit
increas
risk
death
severalfold
increas
suscept
infect
mani
countri
mortal
rate
increas
children
whose
weightforheight
percentag
standard
greater
children
whose
weightforheight
percentag
standard
less
diseas
cystic
fibrosi
cancer
nutrit
statu
link
close
surviv
rate
morbid
leukemia
lymphoma
incid
infect
p
carinii
higher
patient
proteincalori
malnutrit
biochem
proteincalori
malnutrit
lead
chang
sever
aspect
immun
system
cellmedi
immun
microbi
function
phagocyt
complement
system
secretori
antibodi
antibodi
affin
consist
impair
patient
signific
malnutrit
addit
defici
micronutri
especi
zinc
iron
well
mani
other
may
also
deleteri
effect
immun
system
aspect
immun
alter
proteincalori
malnutrit
includ
impair
chemotaxi
neutrophil
decreas
lysozym
level
serum
secret
interferon
product
antibodi
respons
celldepend
antigen
child
proteincalori
malnutrit
may
also
impair
mucos
immun
lower
concentr
secretori
iga
saliva
nasopharynx
tear
gastrointestin
tract
compar
wellnourish
control
children
similar
children
adult
infect
patient
malabsorpt
tcell
function
depress
peripher
circul
also
intestin
tract
subsequ
plasma
cell
function
macrophag
activ
may
impair
lead
frequent
intestin
infect
children
sever
proteincalori
malnutrit
nutrit
improv
immunolog
function
intestin
tract
nutrient
trophic
essenti
mainten
absorpt
capac
intestin
studi
weight
loss
greater
due
disord
associ
reduct
pancreat
enzym
secret
villou
atrophi
impair
carbohydr
fat
absorpt
disord
promptli
revers
appropri
nutrit
rehabilit
addit
villou
blunt
increas
antigen
uptak
may
also
occur
leav
child
higher
risk
enter
infect
pathogenesi
villou
blunt
current
unclear
may
due
crypt
hyperplasia
primari
event
prematur
slough
villu
tip
vs
loss
enterocyt
villu
tip
result
prolifer
crypt
immunosuppress
medic
mainstay
therapi
mani
diseas
children
autoimmun
disord
inflammatori
bowel
diseas
chronic
pulmonari
diseas
cancer
organ
transplant
best
known
immunosuppress
includ
corticosteroid
azathioprin
ciclosporin
tacrolimu
antithymocyt
globulin
unfortun
effect
medic
target
toward
specif
organ
rather
indiscrimin
suppress
immun
function
throughout
child
thu
sever
immunolog
function
includ
decreas
monocyt
adher
neutrophil
chemotaxi
overal
suppress
inflammatori
respons
found
children
risk
enter
infect
similar
describ
children
infect
gastrointestin
problem
common
signific
accompani
morbid
children
primari
problem
gastrointestin
tract
associ
gastrointestin
malabsorpt
infect
scientif
progress
made
regard
detect
novel
pathogen
contribut
gastrointestin
dysfunct
yet
continu
subset
children
persist
diarrhea
abdomin
pain
indetermin
etiolog
despit
extens
evalu
futur
effort
focu
improv
therapeut
option
treatment
unusu
infect
well
delin
etiolog
chronic
nonpathogen
diarrhea
although
etiolog
immunodefici
disord
cancer
malnutrit
differ
associ
hiv
mani
diagnost
manag
principl
appli
clinician
aggress
evalu
diarrhea
gastrointestin
tract
dysfunct
children
ongo
secondari
immunodefici
